Gilead Sciences has bolstered its position in the development of next-generation cancer cell therapies with a deal to absorb Tmunity Therapeutics into its Kite unit. Kite has agreed to acquire all the ...
(Alliance News) - Britain will spend GBP400 million developing long-range missiles this year as part of "a new deal for European security", the Defence secretary has announced.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results